Author: The Carcinoid Cancer Foundation (CCF)
October Luncheon with the Experts in New York City for the Carcinoid and Neuroendocrine Tumor Community
Join carcinoid and neuroendocrine tumor patients in New York City on Sunday, October 15, 2017 for a unique opportunity to have lunch with three medical experts. Share your experiences with others who have similar concerns and hear from physicians on …
READ MORENew Carcinoid Syndrome Web Series: Education, Testing and Nutrition
The neuroendocrine tumor (NET) community is invited to attend a new national webinar series on carcinoid syndrome, beginning on Wednesday, August 23, 2017 with a presentation by Eric H. Liu, MD, neuroendocrine surgeon at the Rocky Mountain Cancer …
READ MORENew Market Research Study Seeking Neuroendocrine Tumor and Carcinoid Syndrome Patient Participants
Foster Rosenblatt, a leading provider of oncology patient data, is seeking participants in the United States for both telephone interviews and an online survey for neuroendocrine tumor patients who have been clinically diagnosed with a gastrointestinal…
READ MORESeeking Participants for Carcinoid Syndrome and Carcinoid Tumor Focus Groups in July
Schlesinger Associates, a leading medical marketing research specialist, is seeking patients diagnosed with Carcinoid Syndrome and Carcinoid Tumors to participate in small focus group interviews on the topic of Carcinoid Syndrome and associated…
READ MOREZebra Tales: Share Your Self-Care Story about Living with Carcinoid and Neuroendocrine Tumors
The Carcinoid Cancer Foundation and our partner Self Care Catalysts are pleased to launch Zebra Tales, a series of patient and caregiver stories about self-care while living with Carcinoid or other Neuroendocrine Tumors (NETs).
We are inviting you …
READ MOREAcronyms Used in the Carcinoid and Neuroendocrine Tumor Community
(Updated 2022)
Whether you are newly diagnosed, a friend or family member of a carcinoid/neuroendocrine tumor (NET) patient, or someone living with the disease for a long time, the language used in the carcinoid/NET community, especially the acronyms,…
READ MORECarcinoid NETs Health Storylines — Now Available in Seven Countries
The Carcinoid Cancer Foundation (CCF) and our partner Self Care Catalysts (SCC)…
READ MOREMay Luncheon with the Experts in New York City for the Carcinoid and Neuroendocrine Tumor Community
Join carcinoid and neuroendocrine tumor patients in New York City on Sunday, May 21, 2017 for a unique opportunity to have lunch with three medical experts. Share your experiences with others who have similar concerns and hear from physicians on issues…
READ MORESTARTRK-2: A Basket Trial for Neuroendocrine Tumor Patients with Specific Gene Rearrangements
Precision medicine, molecular testing, basket studies, STARTRK-2 – it may sound like technology of the future but it is here today and it might be the answer to slowing or stopping tumor growth for neuroendocrine tumor (NET) patients who have specific…
READ MOREGallium 68 PET/CT Scanning for Neuroendocrine Tumors — Information and Locations (updated January 26, 2019)
The US Food and Drug Administration’s (FDA) June 1, 2016 approval of the Gallium-68 PET/CT DOTATATE scan using NETSPOT® heralded a new age of nuclear imaging for neuroendocrine tumors in the United States.
PLEASE SCROLL DOWN FOR A STATE-BY STATE LIST … READ MORE